Continuing with our EM Mindset series, here is another great piece by Al Lulla to kick off your week. Enjoy!
The challenge of emergency medicine is to determine if a patient has a serious and/or deadly condition, even when he or she presents with a common chief complaint. A simple HA can be life-threatening…
Pulmonary embolism is a life-threatening entity affecting up to 900,000 individuals a year. Unfortunately, D-dimer levels increase with age decreasing the yield of the test. In order to increase the specificity safely, Douma et al. performed a retrospective analysis to derive age-adjusted D-dimer cutoffs. The study developed the age-adjusted D-dimer with a receiver operating characteristics (ROC) curve.14 In JAMA 2014, Righini et al. published a prospective study utilizing the age-adjusted cutoff.
AGE ADJUSTED D-DIMER CUTOFF = (AGE X 10) μg/L
One of the most dangerous times in EM: The Handoff. What can be done better?
Please see prior post here: http://www.emdocs.net/reversal-of-anticoagulation/
On October 16, 2015 the FDA granted accelerated approval of idarucizumab (Praxbind), a novel reversal agent of the direct thrombin inhibitor Dabigatran (Pradaxa), for utilization in life-threatening bleeding emergencies.1
Continuing with our EM Mindset series, here is another great piece by Dr. Tim Horeczko to kick off your week. Enjoy!
Are there any tests that can help you with Giant Cell Arteritis?
Check out this R.E.B.E.L. EM post by Dr. Salim R. Rezaie as we learn the evidence behind the value of a good chest pain history